DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Robimycin is a drug marketed by Robins Ah and is included in one NDA.
The generic ingredient in ROBIMYCIN is erythromycin. There are one hundred and three drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
A generic version of ROBIMYCIN was approved as erythromycin by TORRENT on July 6th, 2020.
Anatomical Therapeutic Chemical (ATC) Classes for ROBIMYCIN
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Robins Ah||ROBIMYCIN||erythromycin||TABLET, DELAYED RELEASE;ORAL||061633-001||Approved Prior to Jan 1, 1982||DISCN||No||No||⤷ Free Forever Trial||⤷ Free Forever Trial||⤷ Free Forever Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|